New Metabolic Disease Articles from our Partners at Consultant 360

DOACs vs VKAs: Which Are Safer for Patients Undergoing TAVI?

It is unclear whether direct oral anticoagulants or vitamin K antagonists are safer among patients undergoing TAVI with concomitant indication of oral anticoagulation. Researchers investigated, and this is what they found.

https://www.consultant360.com/exclusive/cardiology/doacs-vs-vkas-which-are-safer-patients-undergoing-tavi  

Leading Groups Develop Guidance for Arrhythmia Management in Current Climate

The joint document was a collaboration of the Heart Rhythm Society COVID-19 Task Force, the American College of Cardiology Electrophysiology Council, and the American Heart Association Electrocardiography and Arrhythmias Committee.

https://www.consultant360.com/exclusive/cardiology/arrhythmia-ep/leading-groups-develop-guidance-arrhythmia-management-current

Are DOACs Safer Than Warfarin for Patients With AFib?

Because the safety of individual DOACs relative to warfarin for specific bleeding outcomes in patients with atrial fibrillation is unclear, the researchers compared the safety of 3 DOACs with the safety of warfarin.

https://www.consultant360.com/exclusive/cardiology/arrhythmia-ep/are-doacs-safer-warfarin-patients-afib

Spontaneous Bilateral Internal Jugular Vein Clots With 2 Causes of Hypercoagulability

A 37-year-old man presented with left-sided anterolateral neck pain for 1 day that had begun without preceding injury.

https://www.consultant360.com/article/cardiology/spontaneous-bilateral-internal-jugular-vein-clots-2-causes-hypercoagulability

CRP Levels May Be a Risk Factor for Major Adverse Cardiac Events

Because the association between elevated C-reactive protein levels and the risk of angina pectoris is controversial, researchers assessed the relationship in a new meta-analysis.

https://www.consultant360.com/article/cardiology/crp-levels-may-be-risk-factor-major-adverse-cardiac-events